skip to Main Content

Having introduced the broader context and the different ways of viewing prescribed psychiatric drugs in sections 1 and 2 of this guidance, this section considers the implications for therapeutic practice. It invites therapists to reflect on their own position in relation to the biomedical paradigm and to consider a number of key issues in relation to prescription psychiatric drugs. Practice-related guidance includes suggestions for working with clients at different stages of their prescribed drug journey: those who are considering taking prescribed drugs; those who are considering withdrawing; and those who are already withdrawing and who may be experiencing withdrawal reactions. For ease of reference, brief summaries of the evidence presented in sections 4, 5 and 6 are included.

Back To Top